Amedisys Stock Options Expiring on 21st of February

AMED Stock  USD 91.79  0.51  0.56%   
Amedisys' latest option contracts expiring on February 21st 2025 are carrying combined implied volatility of 0.17. The Amedisys option chain provides detailed quote and price information for the current Amedisys option contracts. It shows all of Amedisys' listed puts, calls, expiration dates, strike prices, and other pricing information.

Amedisys Maximum Pain Price Across 2025-02-21 Option Contracts

Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Amedisys close to expiration to expire worthless. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, Amedisys' option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Amedisys' stock options are financial instruments that give investors the right to buy or sell shares of Amedisys common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Amedisys stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Amedisys' stock price goes up or down, the stock options follow.
At present, Amedisys' Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting.

Amedisys In The Money Call Balance

When Amedisys' strike price is surpassing the current stock price, the option contract against Amedisys stock is said to be in the money. When it comes to buying Amedisys' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Amedisys are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Amedisys Current Options Market Mood

Amedisys' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Amedisys Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Volume

Unfortunately, most Amedisys' options investors are not very successful. Amedisys' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Amedisys contract

Base on the Rule 16, the options market is currently suggesting that Amedisys will have an average daily up or down price movement of about 0.0106% per day over the life of the 2025-02-21 option contract. With Amedisys trading at USD 91.79, that is roughly USD 0.009753. If you think that the market is fully incorporating Amedisys' daily price movement you should consider buying Amedisys options at the current volatility level of 0.17%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  

Amedisys Option Chain

When Amedisys' strike price is surpassing the current stock price, the option contract against Amedisys stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Amedisys' option chain is a display of a range of information that helps investors for ways to trade options on Amedisys. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Amedisys. It also shows strike prices and maturity days for a Amedisys against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
AMED250221C00065000065.030.1 - 34.230.1In
Call
AMED250221C00070000070.025.3 - 29.525.3In
Call
AMED250221C00075000075.020.5 - 24.520.5In
Call
AMED250221C00080000080.015.9 - 20.015.9In
Call
AMED250221C00085000085.011.6 - 15.511.6In
Call
AMED250221C00090000090.07.7 - 11.07.7In
Call
AMED250221C00095000095.03.6 - 7.03.6In
Call
AMED250221C001000000100.00.0 - 4.04.0Out
Call
AMED250221C001050000105.00.0 - 2.152.15Out
Call
AMED250221C001100000110.00.0 - 2.152.15Out
 Put
AMED250221P00065000065.00.0 - 2.152.15Out
 Put
AMED250221P00070000070.00.0 - 2.152.15Out
 Put
AMED250221P00075000075.00.0 - 2.352.35Out
 Put
AMED250221P00080000080.00.0 - 2.72.7Out
 Put
AMED250221P00085000085.00.0 - 3.43.4Out
 Put
AMED250221P00090000090.00.1 - 4.50.1Out
 Put
AMED250221P00095000095.02.1 - 5.02.1Out
 Put
AMED250221P001000000100.02.15 - 6.02.15In
 Put
AMED250221P001050000105.06.3 - 10.46.3In
 Put
AMED250221P001100000110.011.3 - 15.411.3In

Amedisys Market Cap Over Time

   Market Cap   
       Timeline  

Amedisys Total Stockholder Equity

Total Stockholder Equity

1.29 Billion

At present, Amedisys' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting.

Amedisys Corporate Management

John NugentChief OfficerProfile
Pete HartleyCTO SystemsProfile
Kendra KimmonsVP RelationsProfile
Jennifer GriffinChief SecretaryProfile
Janet BrittVP CollectionsProfile
Francis MayerSenior DevelopmentProfile
When determining whether Amedisys is a strong investment it is important to analyze Amedisys' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Amedisys' future performance. For an informed investment choice regarding Amedisys Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amedisys. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amedisys. If investors know Amedisys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amedisys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.35)
Earnings Share
2.52
Revenue Per Share
71.004
Quarterly Revenue Growth
0.057
Return On Assets
0.0627
The market value of Amedisys is measured differently than its book value, which is the value of Amedisys that is recorded on the company's balance sheet. Investors also form their own opinion of Amedisys' value that differs from its market value or its book value, called intrinsic value, which is Amedisys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amedisys' market value can be influenced by many factors that don't directly affect Amedisys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amedisys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amedisys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amedisys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.